Dipstick test for meningitis culpritsSeptember 05, 2006Over a million people each year, most of them in the "meningitis belt" in Africa, contract bacterial meningitis, a potentially deadly infection of tissues that line the brain and spinal cord. The disease can be caused by several kinds of bacteria, and identifying the culprit early during an outbreak is critical to its containment. Suzanne Chanteau and colleagues in Niger have now developed a new series of simple and accurate tests that can determine the cause of an outbreak locally. As they describe in a research article in the international open-access medical journal PLoS Medicine, their "dipstick" tests require no fancy laboratory equipment, and not even refrigeration. The tests, done on the patient's spinal fluid (which is obtained as a part of the routine evaluation of someone suspected of having meningitis) can determine whether the disease is caused by one of the four most common groups of meningococcus circulating in Africa. Two paper strips, the "dipsticks", are placed in two separate tubes of the patient's spinal fluid. After several minutes, the appearance of red lines on the dipsticks shows whether one of the four groups of meningococcus is present, and if so, which one. The new dipstick test for meningococcal meningitis represents a major advance for health-care workers in remote locations affected by meningitis epidemics. This test can be stored without refrigeration and used at bedside in the hot temperatures typical of the African savannah during the meningitis season. The dipsticks are easier to use than currently available test kits, give more rapid results, and are more accurate. They promise to be an important tool for guiding individual treatment decisions as well as public health actions, including vaccine selection, against the perennial threat of epidemic meningitis. Public Library of Science |
|||||||||||||||||||||
| Related Meningitis Current Events and Meningitis News Articles Progress made on group B streptococcus vaccine Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have completed a Phase II clinical study that indicates a vaccine to prevent Group B Streptococcus (GBS) infection is possible. Scientists create NICE solution to pneumonia vaccine testing problems Medical clinics the world over could benefit from new software* created at the National Institute of Standards and Technology (NIST), where a team of scientists has found a way to improve the efficiency of a pneumonia vaccine testing method developed at the University of Alabama at Birmingham (UAB). Review: Pneumococcal conjugate vaccines effective at preventing child deaths A study published in The Cochrane Review this month concludes that pneumococcal conjugate vaccines (PCV), already known to prevent invasive pneumococcal disease (IPD) and x-ray defined pneumonia, was also effective against child deaths. Immune cells predict outcome of West Nile virus infection Infection with West Nile virus (WNV) causes no symptoms in most people. However, it can cause fever, meningitis, and/or encephalitis. What determines the outcome of infection with WNV in different people has not been determined. UCF professor finds new way deadly food-borne bacteria spread University of Central Florida Microbiology Professor Keith Ireton has uncovered a previously unknown mechanism that plays an important role in the spread of a deadly food-borne bacterium. New WHO data underscores global threat of the world's leading child killer New World Health Organization data to be published in this week's edition of the Lancet will shed new light on two leading causes of pneumonia, the world's leading killer of children under age 5, both globally and within specific countries. How meningitis bacteria attack the brain A specific protein on the surface of a common bacterial pathogen allows the bacteria to leave the bloodstream and enter the brain, initiating the deadly infection known as meningitis. Microbes and their hosts -- exploring the complexity of symbiosis in DNA and cell biology The unique association between microorganisms and their hosts, whether insects, plants, or mammals, provides a fascinating view into how microbial symbionts adapt to changing biological environments. Breast cancer drug shows promise against serious infections An FDA-approved drug used for preventing recurrence of breast cancer shows promise in fighting life-threatening fungal infections common in immune-compromised patients, such as infants born prematurely and patients with cancer. Ben-Gurion U discovers drug can prevent epilepsy following traumatic brain injury Dr. Alon Friedman, a neurosurgeon, professor and researcher at Ben-Gurion University of the Negev, working with researchers from UC Berkeley, California have identified a TGF Beta Blocker that when given to rats prevents epilepsy after brain damage. More Meningitis Current Events and Meningitis News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||